LLM-Based Agents for Competitive Landscape Mapping in Drug Asset Due Diligence

• URL: http://arxiv.org/abs/2508.16571v3
• Date: Thu, 28 Aug 2025 00:44:09 GMT
• Title: LLM-Based Agents for Competitive Landscape Mapping in Drug Asset Due Diligence
• Abstract summary: We describe and benchmark a competitor-discovery component used within an agentic AI system for fast drug asset due diligence.<n>A competitor-discovery AI agent, given an indication, retrieves all drugs comprising the competitive landscape of that indication.<n>Our competitor-discovery agent achieves 83% recall, exceeding OpenAI Deep Research and Perplexity Labs.
• Score: 0.231749519765552
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: In this paper, we describe and benchmark a competitor-discovery component used within an agentic AI system for fast drug asset due diligence. A competitor-discovery AI agent, given an indication, retrieves all drugs comprising the competitive landscape of that indication and extracts canonical attributes for these drugs. The competitor definition is investor-specific, and data is paywalled/licensed, fragmented across registries, ontology-mismatched by indication, alias-heavy for drug names, multimodal, and rapidly changing. Although considered the best tool for this problem, the current LLM-based AI systems aren't capable of reliably retrieving all competing drug names, and there is no accepted public benchmark for this task. To address the lack of evaluation, we use LLM-based agents to transform five years of multi-modal, unstructured diligence memos from a private biotech VC fund into a structured evaluation corpus mapping indications to competitor drugs with normalized attributes. We also introduce a competitor validating LLM-as-a-judge agent that filters out false positives from the list of predicted competitors to maximize precision and suppress hallucinations. On this benchmark, our competitor-discovery agent achieves 83% recall, exceeding OpenAI Deep Research (65%) and Perplexity Labs (60%). The system is deployed in production with enterprise users; in a case study with a biotech VC investment fund, analyst turnaround time dropped from 2.5 days to $\sim$3 hours ($\sim$20x) for the competitive analysis.

Related papers

• AgentBeats: Agentifying Agent Assessment for Openness, Standardization, and Reproducibility [104.46861849039357]
  Agent systems are advancing quickly across domains, but their evaluation remains fragmented.<n>The root problem is the lack of an open, agent-agnostic assessment interface.<n>We advocate Agentified Agent Assessment (AAA), where evaluation is performed by judge agents and all participants interact through standardized protocols.
  arXiv  Detail & Related papers  (2026-06-11T17:23:54Z)
• Plan First, Judge Later, Run Better: A DMAIC-Inspired Agentic System for Industrial Anomaly Detection [51.90293101535452]
  We propose DMAIC-IAD (DMAIC-inspired Agentic Industrial Anomaly Detection), a "Plan First, Judge Later" multi-agent system.<n>We show DMAIC-IAD improves average detection performance over applicable agentic baselines by 37.76%.
  arXiv  Detail & Related papers  (2026-06-03T08:38:14Z)
• Cattle Trade: A Multi-Agent Benchmark for LLM Bluffing, Bidding, and Bargaining [0.5691230599672109]
  We introduce textscCattle Trade, a benchmark for evaluating large language models (LLMs) as agents in strategic reasoning.<n>The benchmark combines auctions, hidden-offer trade challenges (TCs), bargaining, bluffing, opponent modeling, and resource allocation within a single long-horizon game.<n>We evaluate seven cost-efficient language models and three deterministic code agents across 242 games.
  arXiv  Detail & Related papers  (2026-05-14T08:20:03Z)
• AgentRaft: Automated Detection of Data Over-Exposure in LLM Agents [40.88941407116349]
  We present AgentRaft, the first automated framework for detecting Data Over-Exposure (DOE) risks in Large Language Model (LLM) agents.<n>We evaluate AgentRaft on a testing environment of 6,675 real-world agent tools.
  arXiv  Detail & Related papers  (2026-03-08T09:40:54Z)
• Hunt Globally: Wide Search AI Agents for Drug Asset Scouting in Investing, Business Development, and Competitive Intelligence [0.2242867844843965]
  New drug assets now originate outside the United States and are disclosed primarily via regional, non-English channels.<n>We propose a benchmarking methodology for drug asset scouting and a tuned, tree-based self-learning Bioptic Agent.<n>Our Bioptic Agent achieves 79.7% F1 score, outperforming Claude Opus 4.6 (56.2%), Gemini 3 Pro + Deep Research (50.6%), OpenAI GPT-5.2 Pro (46.6%), Perplexity Deep Research (44.2%), and Exa Websets (26.9%)
  arXiv  Detail & Related papers  (2026-02-16T18:57:49Z)
• SelfAI: Building a Self-Training AI System with LLM Agents [79.10991818561907]
  SelfAI is a general multi-agent platform that combines a User Agent for translating high-level research objectives into standardized experimental configurations.<n>An Experiment Manager orchestrates parallel, fault-tolerant training across heterogeneous hardware while maintaining a structured knowledge base for continuous feedback.<n>Across regression, computer vision, scientific computing, medical imaging, and drug discovery benchmarks, SelfAI consistently achieves strong performance and reduces redundant trials.
  arXiv  Detail & Related papers  (2025-11-29T09:18:39Z)
• Repurposing Synthetic Data for Fine-grained Search Agent Supervision [81.95597592711688]
  LLM-based search agents are increasingly trained on entity-centric synthetic data.<n> prevailing training methods discard this rich entity information, relying instead on sparse, outcome-based rewards.<n>We introduce Entity-aware Group Relative Policy Optimization (E-GRPO), a novel framework that formulates a dense entity-aware reward function.
  arXiv  Detail & Related papers  (2025-10-28T17:50:40Z)
• MedKGent: A Large Language Model Agent Framework for Constructing Temporally Evolving Medical Knowledge Graph [57.54231831309079]
  We introduce MedKGent, a framework for constructing temporally evolving medical Knowledge Graphs.<n>We simulate the emergence of biomedical knowledge via a fine-grained daily time series.<n>The resulting KG contains 156,275 entities and 2,971,384 relational triples.
  arXiv  Detail & Related papers  (2025-08-17T15:14:03Z)
• Beyond Benchmarks: Dynamic, Automatic And Systematic Red-Teaming Agents For Trustworthy Medical Language Models [87.66870367661342]
  Large language models (LLMs) are used in AI applications in healthcare.<n>Red-teaming framework that continuously stress-test LLMs can reveal significant weaknesses in four safety-critical domains.<n>A suite of adversarial agents is applied to autonomously mutate test cases, identify/evolve unsafe-triggering strategies, and evaluate responses.<n>Our framework delivers an evolvable, scalable, and reliable safeguard for the next generation of medical AI.
  arXiv  Detail & Related papers  (2025-07-30T08:44:22Z)
• DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery [54.79763887844838]
  Large language models (LLMs) integrated with autonomous agents hold significant potential for advancing scientific discovery through automated reasoning and task execution.<n>We introduce DrugPilot, a LLM-based agent system with a parameterized reasoning architecture designed for end-to-end scientific in drug discovery.<n>DrugPilot significantly outperforms state-of-the-art agents such as ReAct and LoT, achieving task completion rates of 98.0%, 93.5%, and 64.0% for simple, multi-tool, and multi-turn scenarios, respectively.
  arXiv  Detail & Related papers  (2025-05-20T05:18:15Z)
• LLM Agent Swarm for Hypothesis-Driven Drug Discovery [2.7036595757881323]
  PharmaSwarm is a unified multi-agent framework that orchestrates specialized "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds.<n>By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.
  arXiv  Detail & Related papers  (2025-04-24T22:27:50Z)
• MLRC-Bench: Can Language Agents Solve Machine Learning Research Challenges? [64.62421656031128]
  MLRC-Bench is a benchmark designed to quantify how effectively language agents can tackle challenging Machine Learning (ML) Research Competitions.<n>Unlike prior work, MLRC-Bench measures the key steps of proposing and implementing novel research methods.<n>Even the best-performing tested agent closes only 9.3% of the gap between baseline and top human participant scores.
  arXiv  Detail & Related papers  (2025-04-13T19:35:43Z)
• Preferential Multi-Objective Bayesian Optimization for Drug Discovery [13.740630847478453]
  CheapVS provides preferences regarding the trade-offs between drug properties via pairwise comparison.<n>On a library of 100K chemical candidates targeting EGFR and DRD2, CheapVS outperforms state-of-the-art screening methods in identifying drugs within a limited computational budget.
  arXiv  Detail & Related papers  (2025-03-21T04:27:06Z)
• DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration [24.65716292347949]
  DrugAgent is a multi-agent framework that automates machine learning (ML) programming for drug discovery tasks.<n>Our results show that DrugAgent consistently outperforms leading baselines.
  arXiv  Detail & Related papers  (2024-11-24T03:06:59Z)
• $\ exttt{PatentAgent}$: Intelligent Agent for Automated Pharmaceutical Patent Analysis [17.569006298922783]
  We introduce the $textbffirst$ intelligent agent in this domain, $texttPatentAgent$, poised to advance and potentially revolutionize the landscape of pharmaceutical research. $texttPatentAgent$ comprises three key end-to-end modules -- $textitPA-QA$, $textitPA-Img2Mol$, and $textitPA-CoreId$ -- that respectively perform (1) patent question-answering, (2) image-to-molecular-structure conversion, and (3) core chemical structure identification.
  arXiv  Detail & Related papers  (2024-10-25T19:15:08Z)
• On Speeding Up Language Model Evaluation [48.51924035873411]
  We propose an $textitadaptive$ approach to explore this space.<n>We lean on multi-armed bandits to sequentially identify the next (method, validation sample)-pair to evaluate.<n>We show that it can identify the top-performing method using only 5-15% of the typical resources.
  arXiv  Detail & Related papers  (2024-07-08T17:48:42Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.